Unlock stock picks and a broker-level newsfeed that powers Wall Street.
ASX - Delayed Quote AUD

TALi Digital Limited (TD1.AX)

Compare
0.0010
0.0000
(0.00%)
At close: March 31 at 10:08:56 AM GMT+11
Loading Chart for TD1.AX
  • Previous Close 0.0010
  • Open 0.0010
  • Bid --
  • Ask 0.0020 x --
  • Day's Range 0.0010 - 0.0010
  • 52 Week Range 0.0010 - 0.0020
  • Volume 200,000
  • Avg. Volume 1,370,295
  • Market Cap (intraday) 3.295M
  • Beta (5Y Monthly) 1.52
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Feb 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

TALi Digital Limited, a digital health company, delivers diagnostic and therapeutic solutions to enhance attention cognitive function in Australia. The company provides TALi DETECT, an evidence-based digital screening tool and training module; and TALi TRAIN, a play-based interactions therapy. It also focuses to deliver a series of product developments relevant to attention deficit hyperactivity and disorder; and autism spectrum disorder. The company was formerly known as Novita Healthcare Limited and changed its name to TALI Digital Limited in December 2019. The company was incorporated in 2004 and is headquartered in Camberwell, Australia.

www.talidigital.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: TD1.AX

View More

Performance Overview: TD1.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

TD1.AX
0.00%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

TD1.AX
33.33%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

TD1.AX
89.56%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

TD1.AX
95.96%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: TD1.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TD1.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    3.30M

  • Enterprise Value

    810.40k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    1.73

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -16.00%

  • Return on Equity (ttm)

    -23.35%

  • Revenue (ttm)

    35.27k

  • Net Income Avi to Common (ttm)

    -495.06k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.93M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -291.58k

Research Analysis: TD1.AX

View More

Company Insights: TD1.AX

Research Reports: TD1.AX

View More

People Also Watch